ALKERMES | ALKS - 流动负债

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.56B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	流动负债	更改		日
AbbVie	USD 41.64B		458M	2026-06
Acadia Pharmaceuticals	USD 361.44M		55.91M	2026-06
ALKERMES	USD 662.09M		62.59M	2026-06
Amgen	USD 25.5B		547M	2026-06
Biogen	USD 3.92B		918.2M	2026-06
BioMarin Pharmaceutical	USD 1.66B		870.84M	2026-06
Bristol-Myers Squibb	USD 18.66B		499M	2026-06
Coherus Biosciences	USD 75.51M		56.82M	2026-06
Eli Lilly	USD 47.74B		11.11B	2026-06
Gilead Sciences	USD 11.02B		1.54B	2026-06
Heron Therapeutics	USD 92.14M		1.63M	2026-06
Ionis Pharmaceuticals	USD 315.64M		401.36M	2026-06
J&J	USD 54.9B		2.82B	2026-06
Malin Corporation	EUR 1000K		500K	2024-12
Merck	USD 27.73B		786M	2026-06
Minerva Neurosciences	USD 2.29M		381K	2025-12
Nektar Therapeutics	USD 57.71M		4.17M	2026-03
Neurocrine Biosciences	USD 874.5M		42.8M	2026-06
Otsuka Holdings	JPY 738.96B		52.85B	2026-06
Ovoca Bio	EUR 1.3M		1.11M	2025-12
Pfizer	USD 32.65B		1.7B	2026-06
Regeneron Pharmaceuticals	USD 5.53B		422.9M	2026-06
Vertex Pharmaceuticals	USD 3.94B		57.3M	2026-06